SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2024 financial and operating results on Thursday, October 31, 2024, following the close of trading. Halozyme will host a conference call on...
Halozyme to Report Third Quarter 2024 Financial and Operating Results
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments